George Harb

3.0k total citations · 2 hit papers
30 papers, 1.9k citations indexed

About

George Harb is a scholar working on Surgery, Genetics and Molecular Biology. According to data from OpenAlex, George Harb has authored 30 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Surgery, 12 papers in Genetics and 8 papers in Molecular Biology. Recurrent topics in George Harb's work include Pancreatic function and diabetes (18 papers), Diabetes and associated disorders (11 papers) and Cannabis and Cannabinoid Research (4 papers). George Harb is often cited by papers focused on Pancreatic function and diabetes (18 papers), Diabetes and associated disorders (11 papers) and Cannabis and Cannabinoid Research (4 papers). George Harb collaborates with scholars based in United States, Canada and Japan. George Harb's co-authors include Kenneth E. Sherman, Charles van der Horst, Janet Andersen, Tun Liu, Atul K. Bhan, Margaret James Koziel, Gregory K. Robbins, Paul A. Volberding, Raymond T. Chung and Beverly Alston and has published in prestigious journals such as Nature, New England Journal of Medicine and Journal of the American Chemical Society.

In The Last Decade

George Harb

27 papers receiving 1.9k citations

Hit Papers

Peginterferon Alfa-2a plus Ribavirin versus Interferon Al... 2004 2026 2011 2018 2004 2019 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
George Harb United States 17 920 667 592 501 493 30 1.9k
P. B. Carroll United States 18 743 0.8× 262 0.4× 306 0.5× 209 0.4× 239 0.5× 66 1.6k
Myoung Kuk Jang South Korea 23 398 0.4× 1.0k 1.6× 1.1k 1.8× 312 0.6× 77 0.2× 75 2.0k
Glenn A. Halff United States 21 770 0.8× 623 0.9× 346 0.6× 137 0.3× 69 0.1× 57 1.3k
Sook Hee Hong South Korea 25 404 0.4× 90 0.1× 342 0.6× 648 1.3× 369 0.7× 113 2.2k
Adrian Cotterell United States 26 1.5k 1.6× 1.0k 1.5× 665 1.1× 333 0.7× 380 0.8× 70 2.5k
Daniel S. Smyk United Kingdom 23 348 0.4× 471 0.7× 591 1.0× 193 0.4× 274 0.6× 49 1.4k
Sophie Collardeau‐Frachon France 21 369 0.4× 215 0.3× 244 0.4× 389 0.8× 176 0.4× 93 1.3k
Ioanna Delladetsima Greece 17 207 0.2× 339 0.5× 378 0.6× 275 0.5× 85 0.2× 59 1.1k
Stephen M. Lagana United States 22 615 0.7× 179 0.3× 387 0.7× 714 1.4× 77 0.2× 71 2.1k
Volker Ellenrieder Germany 21 572 0.6× 158 0.2× 405 0.7× 519 1.0× 116 0.2× 111 1.7k

Countries citing papers authored by George Harb

Since Specialization
Citations

This map shows the geographic impact of George Harb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George Harb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George Harb more than expected).

Fields of papers citing papers by George Harb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George Harb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George Harb. The network helps show where George Harb may publish in the future.

Co-authorship network of co-authors of George Harb

This figure shows the co-authorship network connecting the top 25 collaborators of George Harb. A scholar is included among the top collaborators of George Harb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George Harb. George Harb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Fortress, Ashley M., Kiyoharu J. Miyagishima, Sally Temple, et al.. (2023). Stem cell sources and characterization in the development of cell-based products for treating retinal disease: An NEI Town Hall report. Stem Cell Research & Therapy. 14(1). 53–53. 12 indexed citations
3.
Veres, Adrian, Henry L. Bushnell, Elise N. Engquist, et al.. (2019). Charting cellular identity during human in vitro β-cell differentiation. Nature. 569(7756). 368–373. 350 indexed citations breakdown →
4.
Wang, Peng, Esra Karaköse, Hongtao Liu, et al.. (2018). Combined Inhibition of DYRK1A, SMAD, and Trithorax Pathways Synergizes to Induce Robust Replication in Adult Human Beta Cells. Cell Metabolism. 29(3). 638–652.e5. 116 indexed citations
5.
Mace, Sharon E., George Harb, Keith Friend, et al.. (2013). Cost-effectiveness of recombinant human hyaluronidase-facilitated subcutaneous versus intravenous rehydration in children with mild to moderate dehydration. The American Journal of Emergency Medicine. 31(6). 928–934. 11 indexed citations
6.
Spandorfer, Philip R., Sharon E. Mace, Pamela J. Okada, et al.. (2012). A Randomized Clinical Trial of Recombinant Human Hyaluronidase-Facilitated Subcutaneous Versus Intravenous Rehydration in Mild to Moderately Dehydrated Children in the Emergency Department. Clinical Therapeutics. 34(11). 2232–2245. 28 indexed citations
7.
Harb, George, et al.. (2011). Techniques for Hyaluronidase-Facilitated Subcutaneous Fluid Administration With Recombinant Human Hyaluronidase. Journal of Infusion Nursing. 34(5). 300–307. 5 indexed citations
8.
Dexter, Franklin, et al.. (2011). Cost-effectiveness Analysis of Antiarrhythmic Therapies for the Treatment of Supraventricular Tachycardia. CHEST Journal. 140(4). 210A–210A.
9.
Harb, George. (2010). Communication Infrastructures, Institutional Efficiency and EU-Arab Trade: Assessment and Implications. Review of Middle East Economics and Finance. 6(2). 1 indexed citations
10.
Allen, Coburn H., Melissa K. Miller, Sharon E. Mace, et al.. (2009). Recombinant Human Hyaluronidase-Enabled Subcutaneous Pediatric Rehydration. PEDIATRICS. 124(5). e858–e867. 43 indexed citations
11.
Solari, Mario G., Imene Boumaza, Jashvant D. Unadkat, et al.. (2009). Marginal mass islet transplantation with autologous mesenchymal stem cells promotes long-term islet allograft survival and sustained normoglycemia. Journal of Autoimmunity. 32(2). 116–124. 103 indexed citations
13.
Harb, George, Rupangi C. Vasavada, David Cobrinik, & Andrew F. Stewart. (2009). The Retinoblastoma Protein and Its Homolog p130 Regulate the G1/S Transition in Pancreatic β-Cells. Diabetes. 58(8). 1852–1862. 26 indexed citations
14.
Fiaschi‐Taesch, Nathalie, Brian M. Sicari, Karen K. Takane, et al.. (2009). Survey of the Human Pancreatic β-Cell G1/S Proteome Reveals a Potential Therapeutic Role for Cdk-6 and Cyclin D1 in Enhancing Human β-Cell Replication and Function In Vivo. Diabetes. 58(4). 882–893. 98 indexed citations
15.
Harb, George, Suraj Unniappan, Travis D. Webber, et al.. (2008). Treatment of Obesity and Diabetes in Mice by Transplant of Gut Cells Engineered to Produce Leptin. Molecular Therapy. 16(6). 1138–1145. 11 indexed citations
17.
Harb, George & Gregory S. Korbutt. (2006). Effect of prolonged in vitro exposure to high glucose on neonatal porcine pancreatic islets. Journal of Endocrinology. 191(1). 37–44. 8 indexed citations
18.
Kobayashi, Tsunehiro, George Harb, Ray V. Rajotte, et al.. (2006). Immune mechanisms associated with the rejection of encapsulated neonatal porcine islet xenografts. Xenotransplantation. 13(6). 547–559. 38 indexed citations
19.
Kobayashi, Tsunehiro, George Harb, & Gina R. Rayat. (2005). Prolonged Survival of Microencapsulated Neonatal Porcine Islets in Mice Treated with a Combination of Anti-CD154 and Anti-LFA-1 Monoclonal Antibodies. Transplantation. 80(6). 821–827. 23 indexed citations
20.
Chung, Raymond T., Janet Andersen, Paul A. Volberding, et al.. (2004). Peginterferon Alfa-2a plus Ribavirin versus Interferon Alfa-2a plus Ribavirin for Chronic Hepatitis C in HIV-Coinfected Persons. New England Journal of Medicine. 351(5). 451–459. 674 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026